Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
IMCD NVCHIX:IMCDA 84 Debt-to-EBITDA is 3.77 as of Dec. 2025, which is 63% above its 10-year median of 2.31. GuruFocus rates CHIX:IMCDA with a GF Score™ of 84/100 and a GF Value™ of €141.82 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 1,234 Chemicals companies, IMCD NV ranks worse than 64.18% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for IMCD NV's Debt-to-EBITDA or its related term are showing as below:
CHIX:IMCDa'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 1.04 Med: 2.31 Max: 3.41
Current: 3.41
During the past 13 years, the highest Debt-to-EBITDA Ratio of IMCD NV was 3.41. The lowest was 1.04. And the median was 2.31.
CHIX:IMCDa's Debt-to-EBITDA is ranked worse than 64.18% of 1234
companies
in the Chemicals industry
Industry Median: 2.155
vs CHIX:IMCDa: 3.41
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
IMCD NV Debt-to-EBITDA Related Terms
IMCD NV Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for IMCD NV's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:IMCDA vs LIN, SHW, ECL: Debt-to-EBITDA Comparison
For the Specialty Chemicals subindustry, IMCD NV's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IMCD NV Debt-to-EBITDA vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, IMCD NV's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where IMCD NV's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is two times the quarterly (Dec. 2025) EBITDA data.
IMCD NV (CHIX:IMCDA) has a Debt-to-EBITDA of 3.77 as of Dec. 2025. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on IMCD NV. This is 63% above median its historical median of 2.31. Over the past decade, IMCD NV's Debt-to-EBITDA has ranged from 1.04 to 3.41. According to the industry distribution chart, IMCD NV ranks #792 out of 1234 companies in the Chemicals industry, placing it in the top 64.2%.
Is IMCD NV's Debt-to-EBITDA too high?
IMCD NV's current Debt-to-EBITDA of 3.77 is 63% above median its 10-year median of 2.31. Over the past 10 years, this metric has ranged from a low of 1.04 to a high of 3.41. The Chemicals industry median Debt-to-EBITDA is 2.16. IMCD NV's value of 3.77 is 74.9% above this industry median. Based on the distribution chart, IMCD NV ranks #792 out of 1234 companies in the Chemicals industry, which is below the industry midpoint. Overall, IMCD NV has a GF Score™ of 84/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does IMCD NV's Debt-to-EBITDA compare to LIN and SHW?
According to the Chemicals industry distribution chart, IMCD NV ranks #792 out of 1234 companies for Debt-to-EBITDA. This places IMCD NV in the lower half of its industry. The industry median Debt-to-EBITDA is 2.16. IMCD NV's value of 3.77 is 74.9% above this benchmark. Historically, IMCD NV's own Debt-to-EBITDA has ranged from 1.04 to 3.41 over the past decade. While the company's 10-year median is 2.31 vs. the industry median of 2.16, IMCD NV has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Chemicals company?
The median Debt-to-EBITDA among Chemicals companies is 2.16, based on 1,234 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. IMCD NV's current Debt-to-EBITDA of 3.77 is 74.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on IMCD NV. For the Chemicals industry, the median Debt-to-EBITDA is 2.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IMCD NV's current Debt-to-EBITDA is 3.77, which is 63% above median its own 10-year median of 2.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IMCD NV stock overvalued right now?
Based on GuruFocus' analysis, IMCD NV (CHIX:IMCDA) is currently considered Significantly Undervalued. The stock's GF Value™ is €141.82, compared to a current price of €79.78 — trading 43.7% below its estimated fair value. The current Debt-to-EBITDA is 3.77, which is 63% above median its 10-year median of 2.31 and 74.9% above the Chemicals industry median of 2.16. IMCD NV's overall GF Score™ is 84/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For IMCD NV (CHIX:IMCDA), the current Debt-to-EBITDA is 3.77 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IMCD NV (CHIX:IMCDA) Overvalued in 2026?
Based on GuruFocus' analysis, IMCD NV stock appears to be undervalued.
The current stock price of €79.78 is trading 43.7% below its estimated GF Value™ of €141.82.
GuruFocus considers IMCD NV to be Significantly Undervalued.
Key valuation signals for CHIX:IMCDA:
Debt-to-EBITDA: 3.77 (63% above median its 10-year median of 2.31)
GF Value™: €141.82 vs. price of €79.78 (43.7% below fair value)
Industry Position: 74.9% above the Chemicals median (#792 of 1234)
No single metric tells the full story. See the CHIX:IMCDA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
IMCD NV is a distributor and formulator of specialty chemicals and ingredients for industrial and life-science markets. The company's product portfolio consists of two categories: Life Science, which consists of the following lines of business: Pharmaceuticals, Beauty & Personal Care, Food & Nutrition, and Home Care I&I, and the Industrial segment, which contains the lines of business of Coatings & Construction, Lubricants & Energy, Industrial Solutions and Advanced Materials. The company has four operating segments: EMEA, Americas, Asia-Pacific, and Holding companies. It derives a majority of its revenue from the EMEA segment, which includes Europe, Turkiye, Israel, Egypt, the United Arab Emirates, Saudi Arabia and Africa.
84GF Score
Get the complete analysis for CHIX:IMCDA
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:IMCDA has been successfully added to your 
